Evolent Health, Inc. (EVH) stock
EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3029% below fair value
$4.90+0.13 (+2.73%)
Close on Nov 13, 2026Market cap $553.99MP/E –Yield –
Evolent Health profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Evolent Health's profit margin for the twelve months ending Sep 30, 2026 was -21.7%. For fiscal 2025 it was -28.5%, against -2.4% the year before. The highest annual figure on record is 343.2% in fiscal 2015.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -28.5% | −26.1 |
| FY2024 | Dec 31, 2024 | -2.4% | +3.3 |
| FY2023 | Dec 31, 2023 | -5.8% | −4.3 |
| FY2022 | Dec 31, 2022 | -1.4% | +2.7 |
| FY2021 | Dec 31, 2021 | -4.1% | +32.0 |
| FY2020 | Dec 31, 2020 | -36.1% | +7.8 |
| FY2019 | Dec 31, 2019 | -43.9% | −35.5 |
| FY2018 | Dec 31, 2018 | -8.4% | +5.6 |
| FY2017 | Dec 31, 2017 | -13.9% | +48.9 |
| FY2016 | Dec 31, 2016 | -62.8% | −406.1 |
| FY2015 | Dec 31, 2015 | 343.2% | +265.2 |
| FY2013 | Dec 31, 2013 | 78.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -3.2% | +1.1 |
| Q2 FY2026 | Jun 30, 2026 | -4.3% | +0.1 |
| Q1 FY2026 | Mar 31, 2026 | -5.4% | +8.0 |
| Q4 FY2025 | Dec 31, 2025 | -91.6% | −88.0 |
| Q3 FY2025 | Sep 30, 2025 | -4.4% | −0.6 |
| Q2 FY2025 | Jun 30, 2025 | -4.5% | −4.7 |
| Q1 FY2025 | Mar 31, 2025 | -13.4% | −10.7 |
| Q4 FY2024 | Dec 31, 2024 | -3.5% | +2.5 |
| Q3 FY2024 | Sep 30, 2024 | -3.7% | +1.2 |
| Q2 FY2024 | Jun 30, 2024 | 0.2% | +7.6 |
| Q1 FY2024 | Mar 31, 2024 | -2.7% | +2.0 |
| Q4 FY2023 | Dec 31, 2023 | -6.0% | −3.0 |
| Q3 FY2023 | Sep 30, 2023 | -5.0% | −5.6 |
| Q2 FY2023 | Jun 30, 2023 | -7.3% | −5.9 |
| Q1 FY2023 | Mar 31, 2023 | -4.7% | −2.9 |
| Q4 FY2022 | Dec 31, 2022 | -3.0% | −0.7 |
| Q3 FY2022 | Sep 30, 2022 | 0.6% | +6.5 |
| Q2 FY2022 | Jun 30, 2022 | -1.4% | +2.7 |
| Q1 FY2022 | Mar 31, 2022 | -1.8% | +2.8 |
| Q4 FY2021 | Dec 31, 2021 | -2.3% | +3.7 |
| Q3 FY2021 | Sep 30, 2021 | -5.9% | +9.7 |
| Q2 FY2021 | Jun 30, 2021 | -4.1% | +89.6 |
| Q1 FY2021 | Mar 31, 2021 | -4.6% | +31.0 |
| Q4 FY2020 | Dec 31, 2020 | -5.9% | +77.8 |
| Q3 FY2020 | Sep 30, 2020 | -15.6% | −4.0 |
| Q2 FY2020 | Jun 30, 2020 | -93.7% | −77.2 |
| Q1 FY2020 | Mar 31, 2020 | -35.6% | −12.0 |
| Q4 FY2019 | Dec 31, 2019 | -83.8% | −75.1 |
| Q3 FY2019 | Sep 30, 2019 | -11.6% | −3.3 |
| Q2 FY2019 | Jun 30, 2019 | -16.5% | −9.6 |
| Q1 FY2019 | Mar 31, 2019 | -23.6% | −13.9 |
| Q4 FY2018 | Dec 31, 2018 | -8.6% | +2.9 |
| Q3 FY2018 | Sep 30, 2018 | -8.3% | +3.4 |
| Q2 FY2018 | Jun 30, 2018 | -6.9% | +8.9 |
| Q1 FY2018 | Mar 31, 2018 | -9.8% | +7.2 |
| Q4 FY2017 | Dec 31, 2017 | -11.6% | +8.2 |
| Q3 FY2017 | Sep 30, 2017 | -11.7% | – |
| Q2 FY2017 | Jun 30, 2017 | -15.8% | – |
| Q1 FY2017 | Mar 31, 2017 | -17.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -19.8% | – |
See a number that looks wrong?